arBtrage CAPITALIZING MARKETS checking… Sign in Sign up

Enliven Therapeutics, Inc.

ELVN Health Care Biotechnology: Pharmaceutical Preparations
$34.71
▼ -2.2% Today
as of Jun 7, 07:13 ET
Last 30 days -19.24% Apr 28 → Jun 05
$34.00 $36.57 $39.14 $41.70 $44.27 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$35.44
High
$36.07
Low
$33.68
Volume
$1M
Avg Vol
$805,844
Mkt Cap
$2.5B
P/E (TTM)
Beta
52w High
$48.53
52w Low
$14.79
Div Yield
Shares Out
$61M

Overview

52-week range
$15
$49
59% of range
Avg surprise (last 2)
+0.9%
Avg reaction (last 2)
-1.5%
0% positive
Latest IV / EM
250%
EM ±34.6% · $35 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.57$-0.51$-0.44$-0.38$-0.32 Actual $-0.41Actual $-0.51Actual $-0.54Actual $-0.41Actual $-0.48Actual $-0.57Est $-0.51Actual $-0.49Actual $-0.32Actual $-0.38Est $-0.44 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-29M$-27M$-25M$-23M$-21M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Thu May 7, 2026Mar/2026 $-0.38 $-0.44 +13.6% +33.3% -2.2% earnings
Tue Sep 30, 2025Sep 2025 $-0.32 financials
Mon Jun 30, 2025Jun 2025 $-0.49 financials
Wed May 14, 2025Mar/2025 $-0.57 $-0.51 -11.8% -0.7% earnings
Mon Sep 30, 2024Sep 2024 $-0.48 financials
Sun Jun 30, 2024Jun 2024 $-0.41 financials
Sun Mar 31, 2024Mar 2024 $-0.54 financials
Sat Sep 30, 2023Sep 2023 $-0.51 financials
Fri Jun 30, 2023Jun 2023 $-0.41 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue
Cost of revenue
Gross profit
Operating income$-28M$-25M$-29M$-32M$-27M$-25M
Net income$-24M$-20M$-25M$-29M$-23M$-20M
EPS (diluted)$-0.38$-0.32$-0.49$-0.57$-0.48$-0.41

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$132M$99M$102M$119M$102M$124M$101M$97M
Inventory
Total current assets$463M$475M$483M$496M$294M$318M$297M$318M
Total assets$465M$476M$491M$504M$303M$326M$305M$327M
Long-term debt
Total liabilities$11M$17M$15M$15M$14M$16M$17M$22M
Total equity$453M$460M$476M$488M$288M$310M$288M$305M

Implied volatility — last 90 days

244%247%249%252%254% Jun 07 — IV 250% · EM ±34.6%

Sector peers

🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.